Fresenius Medical Care KGAA ST (FMEN)

1,591.02
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    1,591.02 - 1,591.02
Trading near 52-week High

Fresenius Medical Care has hit the highest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

1 / 2

FMEN Overview

Prev. Close
1,517.2
Day's Range
1,591.02-1,591.02
Revenue
-
Open
1,591.02
52 wk Range
1,591.02-1,591.02
EPS
2.75
Volume
0
Market Cap
164.97B
Dividend (Yield)
1.35
(1.66%)
Average Vol. (3m)
4,406
P/E Ratio
12.45
Beta
0.899
1-Year Change
0%
Shares Outstanding
293,413,449
Next Earnings Date
-
What is your sentiment on Fresenius Medical Care?
or
Market is currently closed. Voting is open during market hours.

Fresenius Medical Care KGAA ST News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Fresenius Medical Care KGAA ST Analysis

Fresenius Medical Care KGAA ST Company Profile

Fresenius Medical Care KGAA ST Company Profile

Employees
122909
Market
Germany
  • Type:Equity
  • Market:Mexico
  • ISIN:DE0005785802

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary
  • Hi
    0
    • What is going on? Why so much volatility?
      0
      • Undervalued stock
        0
        • Foolish
          1
          • Resultats del 2020?
            0
            • shorting
              2
              • test
                1
                • Why the quarterly data are so "old" on this Financial Summary ?
                  0
                  • near to downtrend triangle
                    0